CORRESP 1 filename1.htm

Health Sciences Acquisitions Corporation 2
40 10th Avenue, Floor 7
New York, NY 10014

 

December 15, 2022

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

 

Attn: Doris Stacey Gama
 Dorrie Yale

 

RE: Health Sciences Acquisitions Corporation 2
  Amendment No. 4 to Registration Statement on Form S-4
  Filed December 13, 2022
  File No. 333-266660                          

 

Dear Ms. Gama and Ms. Yale:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the registrant, Health Sciences Acquisitions Corporation 2, hereby requests acceleration of effectiveness of the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time on December 16, 2022, or as soon as practicable thereafter.

 

  Very truly yours,
   
  HEALTH SCIENCES ACQUISITIONS CORPORATION 2
     
  By: /s/ Roderick Wong
    Roderick Wong, MD
    Chief Executive Officer